share_log

Finch Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Chief Executive Officer Blischak Matthew P.

Finch Therapeutics | 4/A:持股变动声明(修正)-首席执行官 Blischak Matthew P.

SEC announcement ·  2023/06/23 16:30
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息